Business Description
BrightPath Biotherapeutics Co Ltd
ISIN : JP3274140007
Description
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.74 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.32 | |||||
| Beneish M-Score | 2.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -73.4 | |||||
| 3-Year EBITDA Growth Rate | 19.4 | |||||
| 3-Year EPS without NRI Growth Rate | 20.8 | |||||
| 3-Year FCF Growth Rate | 21.8 | |||||
| 3-Year Book Growth Rate | -41.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.77 | |||||
| 9-Day RSI | 47.33 | |||||
| 14-Day RSI | 44.78 | |||||
| 6-1 Month Momentum % | -5.17 | |||||
| 12-1 Month Momentum % | -33.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.14 | |||||
| Quick Ratio | 4.14 | |||||
| Cash Ratio | 3.87 | |||||
| Days Sales Outstanding | 114.06 | |||||
| Days Payable | 329.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 75 | |||||
| Operating Margin % | -1604276.39 | |||||
| Net Margin % | -1622336.11 | |||||
| FCF Margin % | -1617455.56 | |||||
| ROE % | -116.82 | |||||
| ROA % | -84.66 | |||||
| ROIC % | -334.4 | |||||
| ROC (Joel Greenblatt) % | -2920.31 | |||||
| ROCE % | -110.02 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 44000 | |||||
| PB Ratio | 2.99 | |||||
| Price-to-Tangible-Book | 3.12 | |||||
| EV-to-EBIT | -2.32 | |||||
| EV-to-EBITDA | -2.32 | |||||
| EV-to-Revenue | 37625.09 | |||||
| EV-to-FCF | -2.11 | |||||
| Price-to-Net-Current-Asset-Value | 3.25 | |||||
| Price-to-Net-Cash | 3.58 | |||||
| Earnings Yield (Greenblatt) % | -43.12 | |||||
| FCF Yield % | -29.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BrightPath Biotherapeutics Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 0.072 | ||
| EPS (TTM) (円) | -18.21 | ||
| Beta | 0.64 | ||
| Volatility % | 38.81 | ||
| 14-Day RSI | 44.78 | ||
| 14-Day ATR (円) | 2.305975 | ||
| 20-Day SMA (円) | 47.35 | ||
| 12-1 Month Momentum % | -33.73 | ||
| 52-Week Range (円) | 41 - 99 | ||
| Shares Outstanding (Mil) | 85.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BrightPath Biotherapeutics Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BrightPath Biotherapeutics Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
BrightPath Biotherapeutics Co Ltd Frequently Asked Questions
What is BrightPath Biotherapeutics Co Ltd(TSE:4594)'s stock price today?
The current price of TSE:4594 is 円46.00. The 52 week high of TSE:4594 is 円99.00 and 52 week low is 円41.00.
When is next earnings date of BrightPath Biotherapeutics Co Ltd(TSE:4594)?
The next earnings date of BrightPath Biotherapeutics Co Ltd(TSE:4594) is .
Does BrightPath Biotherapeutics Co Ltd(TSE:4594) pay dividends? If so, how much?
BrightPath Biotherapeutics Co Ltd(TSE:4594) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers